| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 6020 | 2020 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1764 | 2021 |
| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 ACTIV-3/TICO LY-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 329 | 2021 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 124 | 2022 |
| Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge NJU Fuglebjerg, TO Jensen, N Hoyer, CK Ryrsø, B Lindegaard, ... International Journal of Infectious Diseases 99, 100-101, 2020 | 83 | 2020 |
| Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels: a randomized controlled trial ACTIV-3/TICO Bamlanivimab Study Group* Annals of internal medicine 175 (2), 234-243, 2022 | 57 | 2022 |
| Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: A randomised, double-blind, phase 3 trial TL Holland, AA Ginde, R Paredes, TA Murray, N Engen, G Grandits, ... The Lancet Respiratory Medicine 10 (10), 972-984, 2022 | 55 | 2022 |
| Improved survival among hospitalized patients with coronavirus disease 2019 (COVID-19) treated with remdesivir and dexamethasone. A nationwide population-based cohort study T Benfield, J Bodilsen, C Brieghel, ZB Harboe, M Helleberg, C Holm, ... Clinical Infectious Diseases 73 (11), 2031-2036, 2021 | 53 | 2021 |
| A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 AL Tølbøll Sørensen, M Rolland, J Hartmann, ZB Harboe, C Roed, ... Blood Advances 5 (12), 2569-2574, 2021 | 47 | 2021 |
| Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial MN Polizzotto, J Nordwall, AG Babiker, A Phillips, DM Vock, N Eriobu, ... The Lancet 399 (10324), 530-540, 2022 | 42 | 2022 |
| First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study JG Holler, R Eriksson, TØ Jensen, M Van Wijhe, TK Fischer, OS Søgaard, ... BMC Infectious Diseases 21, 1-16, 2021 | 42 | 2021 |
| Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study OS Søgaard, J Reekie, IS Johansen, H Nielsen, T Benfield, L Wiese, ... Clinical Microbiology and Infection 28 (8), 1126-1133, 2022 | 39 | 2022 |
| Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study T Benfield, J Bodilsen, C Brieghel, ZB Harboe, M Helleberg, C Holm, ... Clinical Infectious Diseases, ciab536, 2021 | 34 | 2021 |
| The association of baseline plasma SARS-CoV-2 nucleocapsid antigen level and outcomes in patients hospitalized with COVID-19 ACTIV-3/TICO Study Group Annals of internal medicine 175 (10), 1401-1410, 2022 | 33 | 2022 |
| A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting TO Jensen, P Robertson, R Whybin, I Chambers, M Lahra, W Rawlinson, ... Journal of clinical microbiology 53 (5), 1709-1711, 2015 | 33 | 2015 |
| A role for antimicrobial stewardship in clinical sepsis pathways: a prospective interventional study J Burston, S Adhikari, A Hayen, H Doolan, ML Kelly, K Fu, TO Jensen, ... infection control & hospital epidemiology 38 (9), 1032-1038, 2017 | 32 | 2017 |
| Intraventricular neurocysticercosis: Presentation, diagnosis and management TO Jensen, JJ Post Asian Pacific journal of tropical medicine 9 (8), 815-818, 2016 | 32 | 2016 |
| Predictive validity of the qSOFA criteria for sepsis in non-ICU inpatients E Forward, P Konecny, J Burston, S Adhikari, H Doolan, T Jensen Intensive Care Medicine 43, 945-946, 2017 | 27 | 2017 |
| Outbreak of respiratory syncytial virus (RSV) infection in immunocompromised adults on a hematology ward TO Jensen, S Stelzer‐Braid, C Willenborg, C Cheung, D Andresen, ... Journal of medical virology 88 (10), 1827-1831, 2016 | 24 | 2016 |
| Female genital schistosomiasis and HIV: research urgently needed to improve understanding of the health impacts of this important coinfection DP O'Brien, N Ford, AG Djirmay, A Calmy, M Vitoria, TO Jensen, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (5), 489-493, 2019 | 19 | 2019 |
